Moberg Analytics привлекает венчурные инвестиции для внедрения ИИ в мониторинг пациентов

Startup profile: Moberg Analytics - Founded by: Dick Moberg - Year founded: 2020 - Headquarters: Philadelphia, PA - Sector: Medtech - Funding and valuation: $600,000 raised at an undisclosed valuation, according to PitchBook - Key ecosystem partners: Ben Franklin Technology Partners, University City Science Center After selling his last medtech company, Dick Moberg could’ve walked away from building brain-monitoring technology. Then AI changed what was possible. Now he’s raising venture capital for the first time in decades to turn patient monitoring data into a clinical decision platform. Moberg is the founder and CEO of Moberg Analytics, a startup building software that collects data from healthcare monitors and helps providers interpret it. “What we did in my last company is get all this data together on a display,” he told Technical.ly. “What we’re doing in my new company is taking that data and adding AI and analytics to it to try to guide the [doctors] and nurses who are managing the patient to actually do more precision care.” Moberg’s platform collects data from brain monitors and other devices that track a patient’s vitals, like heart and lung monitors. The system also taps into electronic medical records to identify medications the patient is taking. So far, the company is working with nine hospitals in the United States and Europe, Moberg said. He tapped his network from past companies to help support the startup. It’s Moberg’s fourth brain-monitoring product and third company. He worked for the University of Pennsylvania spinout Interspec for almost 10 years from 1980 to 1989, where he developed a device to monitor brain and spinal cord activity during surgery. In 1990, he spun off his first company, Moberg Medical, from that first device and continued working on brain monitoring technology. In 1998, he started Moberg ICU Solutions, a product that aggregated data about the patient from other monitors. He grew the company for about 20 years before selling to a private equity group. He stayed around for a few years to help with the transition, then moved on during the pandemic to launch Moberg Analytics. The startup is focused on neurocritical care units right now, but similar challenges in other medical units could expand its market, he said. Eventually, Moberg Analytics aims to tap into medical imaging like MRI or CT scans, Moberg said. It’s also testing agentic AI use cases that lets providers “talk to” the data and get an overview of how patients are doing. Scaling toward a new standard of care When Moberg left his second company, Moberg ICU Solutions, he was able to take the remaining funding from a Department of War (DoW) grant with him to launch Moberg Analytics. The company later secured additional DoW and the National Institutes of Health funding as well to keep things going, he said. When the Trump Administration took office in January 2025, there was a lot of uncertainty around grant funding. That’s when one of Moberg Analytics’ grants got cut, and Moberg realized he needed to pivot from relying on government money to revenue and venture funding, he said. Moberg’s last company wasn’t venture-backed, so he was out of practice navigating today’s fundraising environment. The funding and resource environment in Philly is better now than it was 20 years ago, he said, and Ben Franklin Technology Partners led the company’s seed round. “[Ben Franklin] launched the commercial part of our company, and with that money, we’ve now gone and developed a product that is used in hospitals,” he said. The company raised $600,000 toward its $2 million seed round last fall to help test the product. Now, the company is working to raise the rest of it to get regulatory clearances and support research and development, he said. Going forward, Moberg would like the tool to become a standard of care in hospitals, he said. He wants new device makers to integrate with Moberg Analytics from the start. “We want to be the brain sensor hub with our company,” Moberg said. “You can only do that if you have a wide footprint.”